The global in vivo cro market is anticipated to reach USD 5.81 billion by 2026, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.5% during the forecast period. Increasing focus on core competencies by the pharmaceutical players coupled with economic efficiency offered for outsourcing is expected to boost the demand.
In Addition, the CROs are equipped with a competent workforce capable of performing a diverse number of tasks along with being well-versed through regulatory requirements. Also, the pressure from the increasing competition owing to rapid growth of generics, patent expirations, and introduction of biosimilar equivalents are encouraging pharmaceutical companies to take the aid of such organizations.
Increasing mergers and collaborations have propelled the value of pharmaceutical outsourcing with major industry contributors expanding into developing regions. The year 2015 experienced high valued transactions as a result of LabCorp acquiring Covance for USD 5.5 billion and the Chinese Private Equity Group acquiring WuXifor USD 3.3 billion.
In vivo CRO Market Report Highlights
• Rodent based In vivo CRO led the market in 2018 and is anticipated to remain dominant throughout the forecast period. Mice is the most used animal for preclinical evaluation and accounted for almost 76% of the market share in 2018.
• Based on indication, oncology held the largest market share in 2018, attributed to the increasing number of cancer cases and focus of pharmaceutical players on introducing novel drug treatments with fewer side-effects
• North America led the global In vivo CRO market in 2018 owing to the presence of technologically advanced CROs
• Asia Pacific is anticipated to register the fastest CAGR over the forecast period. Constantly improving healthcare infrastructure, huge patient base, presence of untapped opportunities, and economic development, are some factors responsible for the rapid growth
• Some of the key market players include Pharmaceutical Product Development, LLC (PPD); IQVIA; American Preclinical Services, LLC.; Charles River Laboratories; Parexel International Corporation; ICON Plc; Covance Inc.; Theorem Clinical research; inVentiv Health; WuXi AppTec, Inc.; American Preclinical Services, LLC.; and Evotec (US), Inc. Partnership and mergers and acquisitions are the key strategic undertakings by these players
Browse full report with Table of Content @ https://www.grandviewresearch.com/industry-analysis/in-vivo-cro-market
In vivo CRO Market Segmentation
Grand View Research has segmented the In vivo CRO market based on product type, GLP type, indication, and region:
In vivo CRO Product Type Outlook (Revenue, USD Million, 2015 – 2026)
• Rodent Based
• Rats
• Mice
• Others
• Non-Rodent Based
• Hamsters
• Guinea Pigs
• Gerbils
• Others
In vivo CRO GLP Type Outlook (Revenue, USD Million, 2015 – 2026)
• Autoimmune/Inflammatory Conditions
• Rheumatoid Arthritis
• Multiple Sclerosis
• Osteoarthritis
• Irritable Bowel Syndrome
• Others
• Pain Management
• Chronic Pain
• Acute Pain
In vivo CRO Indication Outlook (Revenue, USD Million, 2015 – 2026)
• Non GLP
• In House
• Outsourcing
• GLP Toxicology
• In House
• Outsourcing
• Oncology
• Blood Cancer
• Solid Tumor
• Syngeneic Model
• Patient Derived Xenograft
• Xenograft
• Others
• CNS conditions
• Epilepsy
• Parkinson’s Disease
• Huntington’s Disease
• Stroke
• Traumatic Brain Injury
• ALS
• Muscle Regeneration
• Others
• Diabetes
• Obesity
• Others
In vivo CRO Regional Outlook (Revenue, USD Million, 2015 – 2026)
• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• Spain
• Italy
• France
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Middle East & Africa
• Saudi Arabia
• UAE
• South Africa
For Requesting a Sample Copy of This Report, Please Visit @ https://www.grandviewresearch.com/industry-analysis/in-vivo-cro-market/request/rs1
Browse More Related Report:
Oncology Based In-vivo CRO Market Analysis By Indication (Blood cancer, Solid tumor), By Model (Syngeneic model, Patient Derived Xenograft (PDX), Xenograft), By Region, And Segment Forecasts, 2018 – 2025
Preclinical CRO Market Size, Share & Trends Analysis Report By Service (Toxicology Testing, Bioanalysis & DMPK Studies), By End-use (Biopharmaceutical Companies, Government & Academic Institutes), And Segment Forecasts, 2021 – 2028
About Grand View Research
Grand View Research is a U.S. & India-based market research and consultancy firm. It is headquartered in San Francisco. We provide business insights, syndicated research reports, and customized research reports to large as well as small and medium-scale enterprises. Our database features thousands of statistics and in-depth analyses on more than 45 industries. Grand View Research’s extensive database is used by Fortune 500 companies to understand the regional as well as the global business environment.
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1888202951
Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United States
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/in-vivo-cro-market